Phibro Animal Health (NASDAQ:PAHC) Sets New 52-Week High – Should You Buy?

Phibro Animal Health Co. (NASDAQ:PAHC) hit a new 52-week high during mid-day trading on Wednesday . The stock traded as high as $24.56 and last traded at $24.45, with a volume of 110351 shares trading hands. The stock had previously closed at $24.15.

Analyst Ratings Changes

A number of equities analysts have recently commented on the stock. JPMorgan Chase & Co. initiated coverage on shares of Phibro Animal Health in a report on Tuesday, September 10th. They set a “neutral” rating and a $22.00 price target on the stock. Bank of America lifted their price objective on Phibro Animal Health from $13.00 to $15.00 and gave the stock an “underperform” rating in a research note on Friday, August 30th. Three analysts have rated the stock with a sell rating, two have issued a hold rating and one has given a buy rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Hold” and a consensus target price of $15.00.

Phibro Animal Health Trading Up 2.9 %

The company has a current ratio of 2.94, a quick ratio of 1.64 and a debt-to-equity ratio of 1.79. The firm’s 50-day moving average price is $20.70 and its 200 day moving average price is $18.09. The company has a market cap of $1.01 billion, a price-to-earnings ratio of 77.91, a P/E/G ratio of 0.55 and a beta of 0.52.

Phibro Animal Health (NASDAQ:PAHC) last posted its quarterly earnings results on Wednesday, August 28th. The company reported $0.41 earnings per share for the quarter, beating the consensus estimate of $0.34 by $0.07. The firm had revenue of $273.16 million during the quarter, compared to the consensus estimate of $262.44 million. Phibro Animal Health had a net margin of 0.24% and a return on equity of 18.08%. As a group, equities analysts expect that Phibro Animal Health Co. will post 1.55 EPS for the current year.

Phibro Animal Health Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Wednesday, September 25th. Shareholders of record on Wednesday, September 4th were issued a $0.12 dividend. The ex-dividend date was Wednesday, September 4th. This represents a $0.48 annualized dividend and a yield of 1.93%. Phibro Animal Health’s payout ratio is currently 150.00%.

Insider Activity

In other news, Director E Thomas Corcoran bought 5,000 shares of the business’s stock in a transaction that occurred on Wednesday, September 4th. The shares were bought at an average cost of $20.02 per share, for a total transaction of $100,100.00. Following the acquisition, the director now directly owns 25,000 shares in the company, valued at approximately $500,500. This trade represents a 0.00 % increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Corporate insiders own 50.06% of the company’s stock.

Hedge Funds Weigh In On Phibro Animal Health

Large investors have recently added to or reduced their stakes in the business. Illinois Municipal Retirement Fund raised its stake in shares of Phibro Animal Health by 7.2% in the first quarter. Illinois Municipal Retirement Fund now owns 11,430 shares of the company’s stock worth $148,000 after purchasing an additional 765 shares during the last quarter. CWM LLC boosted its holdings in Phibro Animal Health by 89.8% during the 2nd quarter. CWM LLC now owns 2,188 shares of the company’s stock worth $37,000 after acquiring an additional 1,035 shares during the last quarter. Price T Rowe Associates Inc. MD grew its stake in shares of Phibro Animal Health by 7.4% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 15,393 shares of the company’s stock worth $200,000 after acquiring an additional 1,063 shares in the last quarter. China Universal Asset Management Co. Ltd. raised its holdings in shares of Phibro Animal Health by 65.0% in the first quarter. China Universal Asset Management Co. Ltd. now owns 3,888 shares of the company’s stock valued at $50,000 after purchasing an additional 1,531 shares during the last quarter. Finally, Cardinal Capital Management raised its holdings in shares of Phibro Animal Health by 4.7% in the second quarter. Cardinal Capital Management now owns 56,027 shares of the company’s stock valued at $940,000 after purchasing an additional 2,520 shares during the last quarter. Institutional investors own 99.34% of the company’s stock.

About Phibro Animal Health

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.